• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多巴胺能前体药物的一种极具效力的口服活性苯并[g]喹啉类似物:1-丙基-反式-2,3,4,4a,5,7,8,9,10,10a-十氢-1H-苯并[g]喹啉-6-酮[已校正]

Extremely potent orally active benzo[g]quinoline analogue of the dopaminergic prodrug: 1-propyl-trans-2,3,4,4a,5,7,8,9,10,10a-decahydro-1H-benzo-[g]quinolin-6-one [corrected].

作者信息

Liu Danyang, Wikström Håkan V, Dijkstra Durk, de Vries Jan B, Venhuis Bastiaan J

机构信息

Department of Medicinal Chemistry, University Centre for Pharmacy, University of Groningen, Antonius Deusinglaan 1, NL-9713 AV Groningen, The Netherlands.

出版信息

J Med Chem. 2006 Feb 23;49(4):1494-8. doi: 10.1021/jm051111h.

DOI:10.1021/jm051111h
PMID:16480286
Abstract

Enone prodrugs of dopaminergic catecholamines represent a new type of prodrug in the research area of dopamine agonists. Here, we demonstrate the first benzo[g]quinoline-derived enone that induces potent dopamine agonist effects similar to aminotetralin-derived enones. Significant effects of (-)-4 were observed in microdialysis studies after administration of 1 nmol kg(-1) sc and 3 nmol kg(-1) po. With a potency comparable to that of the most potent apomorphines, (-)-4 could potentially compete with L-DOPA and apomorphine in the treatment of Parkinson's disease.

摘要

多巴胺能儿茶酚胺的烯酮前药是多巴胺激动剂研究领域中的一种新型前药。在此,我们展示了首个苯并[g]喹啉衍生的烯酮,其能诱导出与氨基四氢萘衍生的烯酮相似的强效多巴胺激动剂效应。皮下注射1 nmol kg(-1)和口服3 nmol kg(-1)的(-)-4后,在微透析研究中观察到了显著效果。(-)-4的效力与最有效的阿扑吗啡相当,在帕金森病治疗中可能与左旋多巴和阿扑吗啡形成竞争。

相似文献

1
Extremely potent orally active benzo[g]quinoline analogue of the dopaminergic prodrug: 1-propyl-trans-2,3,4,4a,5,7,8,9,10,10a-decahydro-1H-benzo-[g]quinolin-6-one [corrected].多巴胺能前体药物的一种极具效力的口服活性苯并[g]喹啉类似物:1-丙基-反式-2,3,4,4a,5,7,8,9,10,10a-十氢-1H-苯并[g]喹啉-6-酮[已校正]
J Med Chem. 2006 Feb 23;49(4):1494-8. doi: 10.1021/jm051111h.
2
A novel synthesis and pharmacological evaluation of a potential dopamine D1/D2 agonist: 1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinoline-6,7-diol.一种潜在多巴胺D1/D2激动剂的新型合成及药理学评价:1-丙基-1,2,3,4,4a,5,10,10a-八氢苯并[g]喹啉-6,7-二醇
Bioorg Med Chem. 2008 Mar 15;16(6):3438-44. doi: 10.1016/j.bmc.2007.06.036. Epub 2007 Jun 23.
3
Orally active analogues of the dopaminergic prodrug 6-(N,N-di-n-propylamino)-3,4,5,6,7,8-hexahydro-2H-naphthalen-1-one: synthesis and pharmacological activity.多巴胺能前体药物6-(N,N-二正丙基氨基)-3,4,5,6,7,8-六氢-2H-萘-1-酮的口服活性类似物:合成与药理活性
J Med Chem. 2003 Feb 13;46(4):584-90. doi: 10.1021/jm020990u.
4
Synthesis and dopaminergic properties of benzo-fused analogues of quinpirole and quinelorane.
J Med Chem. 1999 Mar 11;42(5):935-40. doi: 10.1021/jm9804533.
5
Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H [1]b enzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907).多巴胺D3受体选择性激动剂(4aR,10bR)-(+)-反式-3,4,4a,10b-四氢-4-正丙基-2H,5H-[1]苯并吡喃并[4,3-b]-1,4-恶嗪-9-醇(PD 128907)的硫代吡喃类似物的合成及药理学评价
J Med Chem. 2000 Jul 27;43(15):2871-82. doi: 10.1021/jm0000113.
6
A new type of prodrug of catecholamines: an opportunity to improve the treatment of Parkinson's disease.一种新型儿茶酚胺前药:改善帕金森病治疗的契机。
J Med Chem. 2002 Jun 6;45(12):2349-51. doi: 10.1021/jm025508m.
7
[Effects of hemantane on the main subtypes of dopamine receptors in the rat striatum ex vivo].[金刚烷胺对大鼠纹状体多巴胺受体主要亚型的离体效应]
Eksp Klin Farmakol. 2008 Jan-Feb;71(1):18-21.
8
Synthesis and biological characterization of novel hybrid 7-[[2-(4-phenyl-piperazin-1-yl)-ethyl]-propyl-amino]-5,6,7,8-tetrahydro-naphthalen-2-ol and their heterocyclic bioisosteric analogues for dopamine D2 and D3 receptors.新型杂化7-[[2-(4-苯基-哌嗪-1-基)-乙基]-丙基-氨基]-5,6,7,8-四氢萘-2-醇及其多巴胺D2和D3受体的杂环生物电子等排体类似物的合成与生物学特性研究
Bioorg Med Chem. 2004 Aug 15;12(16):4361-73. doi: 10.1016/j.bmc.2004.06.019.
9
N-(Iodopropenyl)-octahydrobenzo[f]- and -[g]quinolines: synthesis and adrenergic and dopaminergic activity studies.
J Med Chem. 1998 Oct 8;41(21):4165-70. doi: 10.1021/jm980284m.
10
Orally active oxime derivatives of the dopaminergic prodrug 6-(N,N-di-n-propylamino)-3,4,5,6,7,8-hexahydro-2H-naphthalen-1-one. Synthesis and pharmacological activity.多巴胺能前药6-(N,N-二正丙基氨基)-3,4,5,6,7,8-六氢-2H-萘-1-酮的口服活性肟衍生物。合成与药理活性。
J Med Chem. 2003 Sep 11;46(19):4136-40. doi: 10.1021/jm0307786.

引用本文的文献

1
Synthesis, Structure Activity Relationship Studies and Pharmacological Evaluation of 2-Phenyl-3-(Substituted Phenyl)-3H-Quinazolin-4-ones as Serotonin 5-HT(2) Antagonists.2-苯基-3-(取代苯基)-3H-喹唑啉-4-酮作为血清素5-HT(2)拮抗剂的合成、构效关系研究及药理评价
Indian J Pharm Sci. 2009 Sep;71(5):572-5. doi: 10.4103/0250-474X.58185.
2
Antiparkinson prodrugs.抗帕金森病前体药物。
Molecules. 2008 Jan 16;13(1):46-68. doi: 10.3390/molecules13010046.